FDA Approves New Bleeding Antidote Andexxa

There is promising news for the more than 4 million patients who take Xarelto® (Riviaroxaban) or Eliquis® (Aixaban) on a daily basis. These blood thinners, while effective, have been shown to cause uncontrolled and sometimes life-threatening bleeding events.  The FDA has finally approved a reversal agent that can stop the anticoagulant effects of Xa inhibitors, in the form…

Details

Xarelto Litigation Update

Plaintiffs from around the nation claim that Bayer’s anticoagulant medication Xarelto was defectively designed and marketed with inadequate warnings about the risk of uncontrolled bleeding. Approved by the FDA in 2011, Xarelto is prescribed to treat blood clots, deep vein thrombosis and pulmonary embolism, and is one of the top-selling blood thinners on the market.…

Details

3M Agrees To $9.1 Million Settlement for Defective Combat Arms Earplugs

3M Combat Arms earplugs were standard-issued to thousands of service members deployed to Iraq and Afghanistan from 2003 to 2015. However, the manufacturer was sued by the U.S. government and competitor Moldex-Metric Inc. when defects were discovered that could cause tinnitus ringing in the ears and hearing impairment. The Veterans Benefits Administration treats over a…

Details

Does Baby Powder Cause Cancer?

Juries say Yes and J&J has known since the 1970’s putting millions of women at risk for ovarian cancer. Scientists originally discovered talc particles in ovarian tumors in the early 1970’s and subsequent studies have showed a link between talcum powder and ovarian cancer. To date J&J continues to claim that their baby powder is…

Details